Definitive chemoradiotherapy for advanced pulmonary sarcomatoid carcinoma

2Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Pulmonary sarcomatoid carcinoma is a rare subtype of non-small cell lung cancer with a poor prognosis. We herein report on a case of pulmonary sarcomatoid carcinoma that was treated successfully by concurrent chemoradiotherapy. A 65-year-old man was diagnosed to have pulmonary pleomorphic carcinoma (clinical T4N2M0 stage IIIB). He received concurrent chemoradiotherapy (60 Gy of radiotherapy in 30 fractionations and two courses of chemotherapy with carboplatin and paclitaxel). After chemoradiotherapy, a significant reduction of the tumor size was observed. Two courses of adjuvant chemotherapy were performed. He is currently alive at 15 months after the first treatment without any recurrence or metastasis.

Cite

CITATION STYLE

APA

Takeda, K., Matsushita, H., Kubozono, M., Tanabe, T., Ishikawa, Y., Yamamoto, T., … Jingu, K. (2016). Definitive chemoradiotherapy for advanced pulmonary sarcomatoid carcinoma. Internal Medicine, 55(22), 3325–3330. https://doi.org/10.2169/internalmedicine.55.6990

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free